Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer

NCT00002679 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

89

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: filgrastim
DRUG: cyclophosphamide
DRUG: doxorubicin hydrochloride
DRUG: paclitaxel
DRUG: tamoxifen citrate
RADIATION: radiation therapy

Sponsor

Yale University